Skip to main content

Table 4 Pharmacologic treatments in CDDP and THD groups

From: The incremental treatment of ESRD: a low-protein diet combined with weekly hemodialysis may be beneficial for selected patients

 

CDDP Group

THD group

P

% of patients

Baseline

12 months

Baseline

12 months

 

ACEi

34

33

50

48.3

n.s

ARBs

24

26

30

21

n.s

Calcium channel blockers

28.9

27.3

30

17

n.s

Calcium carbonate

59

60

76.6

72.4

n.s.

Sevelamer or Lanthanum carbonate

0

12a

0

41c

<0.03

Paricalcitol

0

12b

0

17.2b

n.s.

Cinacalcet

0

6b

0

24c

<0.04

Calcitriol

45

42

46.7

45

n.s.

Kayexalate

21

21

20

38

n.s.

Allopurinol

48.6

54

33.3

13.8a

0.01

Statins

37

33

26.7

24

n.s

Polyunsaturated fats

13

9

10

17

n.s.

  1. Legend: Changes versus baseline: ap<0.05; bp<0.01; c<0.03; P: ANOVA significance for treatment by time interaction.